-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroSense prices $600,000 private placement at $0.8 per share

PUBT·04/28/2026 18:30:22
Listen to the news
NeuroSense prices $600,000 private placement at $0.8 per share
  • NeuroSense Therapeutics priced a private placement of USD 600,000 in ordinary shares.
  • Deal calls for sale of 750,000 ordinary shares at USD 0.8 each.
  • Pricing represents a 6.7% premium to April 27 closing price.
  • CEO Alon Ben-Noon, CFO Or Eisenberg, significant existing shareholder each committed USD 200,000.
  • Closing expected during week of May 3, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202604281430PR_NEWS_USPR_____LN45850) on April 28, 2026, and is solely responsible for the information contained therein.